Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?
Christopher R. ClineCHIEF FINANCIAL OFFICER2024-04-1154$6.74
Sandra CalvinSVP CHIEF ACCOUNTING OFFICER2024-02-012,820$8.53
William E. RoteSENIOR VICE PRESIDENT RD2024-02-012,174$8.53
Christopher R. ClineCHIEF FINANCIAL OFFICER2024-02-013,818$8.53
Eric M. DubeCHIEF EXECUTIVE OFFICER2024-02-0110,016$8.86
Eric M. DubeCHIEF EXECUTIVE OFFICER2024-02-019,106$8.53
Peter HeermaCHIEF COMMERCIAL OFFICER2024-02-014,195$8.53
Jula InrigCHIEF MEDICAL OFFICER2024-02-012,174$8.53
Elizabeth E. ReedSVP GC CORPORATE SECRETARY2024-02-012,590$8.86
Elizabeth E. ReedSVP GC CORPORATE SECRETARY2024-02-012,174$8.53

1 of 3

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?
Ruth Shepley64.36%49,000,000$358.19MInsider
Blackrock Inc10.24%7,796,766$56.99MInstitution
Armistice Capital LLC9.85%7,500,000$54.83MInstitution
Deep Track Capital LP9.68%7,370,000$53.87MInstitution
State Street Corp8.68%6,608,696$48.31MInstitution
Vanguard Group Inc8.23%6,265,829$45.80MInstitution
Macquarie Group Ltd6.06%4,613,059$33.72MInstitution
Morgan Stanley4.63%3,527,620$25.79MInstitution
Rock Springs Capital Management LP4.50%3,424,818$25.04MInstitution
Renaissance Technologies LLC3.76%2,862,014$20.92MInstitution

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX60.31%39.69%Net SellingNet Selling
MREO11.98%4.59%Net BuyingNet Buying
TSHA74.94%16.04%Net Buying
PEPG76.15%18.27%Net BuyingNet Selling
ICU5.06%19.86%Net Buying

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 115.17% institutional shareholders, 75.80% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 64.36% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $358.19M.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.